DK2069798T3 - Elisa til vegf - Google Patents

Elisa til vegf

Info

Publication number
DK2069798T3
DK2069798T3 DK07868362T DK07868362T DK2069798T3 DK 2069798 T3 DK2069798 T3 DK 2069798T3 DK 07868362 T DK07868362 T DK 07868362T DK 07868362 T DK07868362 T DK 07868362T DK 2069798 T3 DK2069798 T3 DK 2069798T3
Authority
DK
Denmark
Prior art keywords
vegf
elisa
Prior art date
Application number
DK07868362T
Other languages
English (en)
Inventor
Yu-Ju G Meng
Johnny Gutierrez
Kyu H Hong
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK2069798T3 publication Critical patent/DK2069798T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK07868362T 2006-10-04 2007-10-03 Elisa til vegf DK2069798T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82820306P 2006-10-04 2006-10-04
PCT/US2007/080310 WO2008060777A2 (en) 2006-10-04 2007-10-03 Elisa for vegf

Publications (1)

Publication Number Publication Date
DK2069798T3 true DK2069798T3 (da) 2014-06-16

Family

ID=39301650

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07868362T DK2069798T3 (da) 2006-10-04 2007-10-03 Elisa til vegf
DK11189401.0T DK2457929T3 (da) 2006-10-04 2007-10-03 Elisa til vegf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK11189401.0T DK2457929T3 (da) 2006-10-04 2007-10-03 Elisa til vegf

Country Status (24)

Country Link
US (5) US20080227119A1 (da)
EP (3) EP3103812B1 (da)
JP (1) JP6025294B2 (da)
KR (2) KR101551984B1 (da)
CN (2) CN103454434B (da)
AR (2) AR063125A1 (da)
AU (1) AU2007319654B2 (da)
BR (1) BRPI0715239A2 (da)
CA (1) CA2663012C (da)
DK (2) DK2069798T3 (da)
ES (2) ES2470682T3 (da)
HR (1) HRP20140675T1 (da)
HU (1) HUE030082T2 (da)
IL (1) IL197374A (da)
MX (2) MX2009003562A (da)
NZ (1) NZ613646A (da)
PL (2) PL2069798T3 (da)
PT (1) PT2069798E (da)
RS (1) RS53387B (da)
RU (2) RU2517301C2 (da)
SI (2) SI2069798T1 (da)
TW (2) TWI429654B (da)
WO (1) WO2008060777A2 (da)
ZA (1) ZA200901518B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009110A1 (en) * 2003-07-08 2005-01-13 Xiao-Jia Chang Methods of producing antibodies for diagnostics and therapeutics
DK2069798T3 (da) 2006-10-04 2014-06-16 Genentech Inc Elisa til vegf
WO2011031986A1 (en) 2009-09-10 2011-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Office Of Technology Transfer, National Institutes Of Health Assays for soluble il-15 receptor alpha
CA2804246A1 (en) * 2010-07-19 2012-01-26 F. Hoffmann-La Roche Ag Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
EP2848939A1 (en) * 2010-07-19 2015-03-18 F. Hoffmann-La Roche AG Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy
CN102207504A (zh) * 2011-03-23 2011-10-05 北京华创远航科技有限公司 一种酶联检测试剂盒及其制备方法
CN102435743B (zh) * 2011-09-15 2014-10-15 北京健平九星生物医药科技有限公司 一种酶联检测试剂盒及其制备方法
CN102426240B (zh) * 2011-09-19 2014-10-15 北京健平金星生物科技有限公司 一种酶联检测试剂盒及其制备方法
CA2853917A1 (en) 2011-12-19 2013-06-27 F. Hoffmann-La Roche Ag Method for the detection of free binding partner of a multispecific binder
KR20140114415A (ko) 2012-01-13 2014-09-26 제넨테크, 인크. Vegf 길항제로의 치료를 위한 환자를 확인하기 위한 생물학적 마커
JP2015507193A (ja) * 2012-02-01 2015-03-05 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 多重特異性結合物の結合パートナーを検出するための方法
CN102645530B (zh) * 2012-04-06 2014-06-18 上海蓝怡科技有限公司 甲状腺素酶联免疫体外诊断试剂盒中酶结合物稀释液的制备方法
MX346146B (es) 2012-07-13 2017-03-09 Hoffmann La Roche Metodo para detectar un aglutinante multiespecifico.
ES2915378T3 (es) 2013-09-13 2022-06-22 Hoffmann La Roche Procedimientos para detectar y cuantificar una proteína de célula huésped en líneas celulares
EP4331605A3 (en) 2013-09-13 2024-05-22 F. Hoffmann-La Roche AG Methods and compositions comprising purified recombinant polypeptides
JP6445573B2 (ja) 2013-10-17 2018-12-26 サルタル セラピューティクス エルティーディＳａｒｔａｒ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｔｄ ヒト患者の固形腫瘍の治療に用いるためのホスホジエステラーゼ阻害剤含有組成物
RU2589286C1 (ru) * 2015-02-03 2016-07-10 Федеральное государственное бюджетное научное учреждение "Томский научно-исследовательский институт онкологии" (Томский НИИ онкологии) Способ прогнозирования исхода заболевания у больных метастатическим раком почки
RU2622005C2 (ru) * 2015-11-24 2017-06-08 Федеральное государственное бюджетное учреждение "Государственный научный центр дерматовенерологии и косметологии" Минздрава России (ФГБУ ГНЦДК Минздрава России) СПОСОБ ПОЛУЧЕНИЯ СЕЛЕКТИВНОГО ИММУНОСОРБЕНТА ДЛЯ УДАЛЕНИЯ АНТИТЕЛ-IgG К ДЕСМОГЛЕИНУ 3 ТИПА ИЗ СЫВОРОТКИ КРОВИ БОЛЬНЫХ ПУЗЫРЧАТКОЙ
CN105510595A (zh) * 2015-12-01 2016-04-20 邹检平 基于量子点CdTe检测人血清中VEGF浓度的试剂盒及其使用方法
EP3485281A1 (en) 2016-07-15 2019-05-22 H. Hoffnabb-La Roche Ag Method and means for detecting the level of total vegf-a
CN107167588A (zh) * 2017-03-28 2017-09-15 马杰 用于检测血清中血管内皮生长因子的抗体及试剂盒
RU2732013C1 (ru) * 2019-12-11 2020-09-10 Федеральное бюджетное учреждение науки "Государственный научный центр прикладной микробиологии и биотехнологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ПМБ) Способ сенсибилизации планшета для иммуноферментного анализа нерастворимыми белковыми антигенами
CN111044734A (zh) * 2019-12-30 2020-04-21 上海复星长征医学科学有限公司 一种用于检测血管内皮生长因子的检测试剂盒及其制备方法和使用方法
KR102676458B1 (ko) 2021-05-20 2024-06-19 대한민국 보툴리눔 독소 a에 특이적인 항체, 이를 생산하는 하이브리도마 세포주, 및 이를 이용한 보툴리눔 독소 a 진단 키트
CN117805397A (zh) * 2024-02-29 2024-04-02 军科正源（北京）药物研究有限责任公司 检测游离vegf的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE337223B (da) 1967-05-23 1971-08-02 Pharmacia Ab
US3720760A (en) 1968-09-06 1973-03-13 Pharmacia Ab Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
DE2031216A1 (de) 1969-06-19 1971-01-14 Citizen Watch Co Ltd , Tokio Tag und Datum Stellvorrichtung fur Uhren mit Kalender
US3691016A (en) 1970-04-17 1972-09-12 Monsanto Co Process for the preparation of insoluble enzymes
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
CA1023287A (en) 1972-12-08 1977-12-27 Boehringer Mannheim G.M.B.H. Process for the preparation of carrier-bound proteins
US4195128A (en) 1976-05-03 1980-03-25 Bayer Aktiengesellschaft Polymeric carrier bound ligands
US4330440A (en) 1977-02-08 1982-05-18 Development Finance Corporation Of New Zealand Activated matrix and method of activation
CA1093991A (en) 1977-02-17 1981-01-20 Hideo Hirohara Enzyme immobilization with pullulan gel
US4229537A (en) 1978-02-09 1980-10-21 New York University Preparation of trichloro-s-triazine activated supports for coupling ligands
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
IE922437A1 (en) 1991-07-25 1993-01-27 Idec Pharma Corp Recombinant antibodies for human therapy
US6020473A (en) * 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
US7005505B1 (en) * 1995-08-25 2006-02-28 Genentech, Inc. Variants of vascular endothelial cell growth factor
DE19532347A1 (de) 1995-09-04 1997-03-06 Bayer Ag 4-Thiocarbamoyl-1-(3-pyrazolyl)-pyrazole
US6750044B1 (en) * 1996-10-17 2004-06-15 Genentech, Inc. Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
JP3957765B2 (ja) 1997-04-07 2007-08-15 ジェネンテク・インコーポレイテッド 抗ｖｅｇｆ抗体
JP3591264B2 (ja) * 1997-12-24 2004-11-17 富士レビオ株式会社 Ｖｅｇｆ１２１特異的モノクローナル抗体及び測定方法
US7078382B1 (en) 1999-11-02 2006-07-18 Genentech, Inc. Modulation of eNOS activity and therapeutic uses thereof
ATE315789T1 (de) * 1999-11-16 2006-02-15 Genentech Inc Elisa für vegf
RU2271010C2 (ru) * 2004-03-31 2006-02-27 Общество с ограниченной ответственностью "Фирма МонА" Способ иммуноферментного анализа для определения фактора виллебранда, моноклональное антитело к фактору виллебранда (варианты) и штамм гибридных культивируемых клеток животных mus. musculus l. - продуцент моноклональных антител к фактору виллебранда (варианты)
AU2006226891A1 (en) * 2005-03-24 2006-09-28 Beth Israel Deaconess Medical Center Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
DK2069798T3 (da) 2006-10-04 2014-06-16 Genentech Inc Elisa til vegf

Also Published As

Publication number Publication date
EP2069798A2 (en) 2009-06-17
CN103454434A (zh) 2013-12-18
HK1232236A1 (en) 2018-01-05
ES2584322T3 (es) 2016-09-27
AU2007319654A1 (en) 2008-05-22
HK1130090A1 (en) 2009-12-18
AR063125A1 (es) 2008-12-30
MX342791B (es) 2016-10-12
CN103454434B (zh) 2016-08-10
US20100255515A1 (en) 2010-10-07
RU2517301C2 (ru) 2014-05-27
KR20150038444A (ko) 2015-04-08
AR107561A2 (es) 2018-05-09
US20170276683A1 (en) 2017-09-28
HUE030082T2 (en) 2017-04-28
TW201406778A (zh) 2014-02-16
US20160033517A1 (en) 2016-02-04
US20130045495A1 (en) 2013-02-21
MX2009003562A (es) 2009-04-15
HRP20140675T1 (hr) 2014-10-10
PL2069798T3 (pl) 2014-09-30
PL2457929T3 (pl) 2016-12-30
US20080227119A1 (en) 2008-09-18
US9625462B2 (en) 2017-04-18
EP2457929B1 (en) 2016-06-08
TWI429654B (zh) 2014-03-11
US8449885B2 (en) 2013-05-28
WO2008060777A3 (en) 2008-07-10
IL197374A0 (en) 2009-12-24
PT2069798E (pt) 2014-06-24
CA2663012A1 (en) 2008-05-22
KR101551984B1 (ko) 2015-09-09
SI2069798T1 (sl) 2014-07-31
EP2457929A1 (en) 2012-05-30
CA2663012C (en) 2017-06-27
ZA200901518B (en) 2010-05-26
HK1168361A1 (en) 2012-12-28
RS53387B (sr) 2014-10-31
RU2014104113A (ru) 2015-08-10
ES2470682T3 (es) 2014-06-24
BRPI0715239A2 (pt) 2013-06-25
EP2069798B1 (en) 2014-04-16
KR101720887B1 (ko) 2017-03-28
RU2009116611A (ru) 2010-11-10
CN101523220A (zh) 2009-09-02
KR20090091695A (ko) 2009-08-28
TW200823233A (en) 2008-06-01
IL197374A (en) 2016-11-30
CN101523220B (zh) 2016-09-21
WO2008060777A2 (en) 2008-05-22
US9146245B2 (en) 2015-09-29
EP3103812B1 (en) 2021-07-28
TWI541251B (zh) 2016-07-11
NZ613646A (en) 2015-03-27
SI2457929T1 (sl) 2016-09-30
AU2007319654B2 (en) 2013-09-12
JP2010506171A (ja) 2010-02-25
JP6025294B2 (ja) 2016-11-16
EP3103812A1 (en) 2016-12-14
DK2457929T3 (da) 2016-09-05

Similar Documents

Publication Publication Date Title
DK2069798T3 (da) Elisa til vegf
EP2305405A4 (en) COATED ELEMENT
EP2267846A4 (en) KONTAKTOR
ES1063346Y (es) Andador
BRPI0907237A2 (pt) Anticorpo anti-cldn6
BRPI0720699A2 (pt) Programas ligados
DK2084443T3 (da) Gennemføring
ATE519215T1 (de) Schaltgerät
FI20070937A0 (fi) Perhekeinu
EP1993006A4 (en) CHRONOGRAPH WATCH
DE602007008903D1 (de) Auspuffrohrstruktur
FI20065834A0 (fi) Iskulaite
DK2091613T3 (da) Anordning til nedsænkning
ATE516593T1 (de) Schaltgerät
FI20085860L (fi) Rakennuselementti
ATE552605T1 (de) Schaltgerät
DK1826334T3 (da) Nødoverløb
DE502006004314D1 (de) Betonzusammensetzung
DE112006003389A5 (de) Geteiltes schwungrad
FI20085306L (fi) Siltarakenne
FI20080435L (fi) Pylväsrakenne
FI20065032A0 (fi) Menetelmä asbestialtistumiseen liittyvien keuhkosyöpien tunnistamiseksi
DE502006004267D1 (de) Umschaltventil
FI20060668A0 (fi) Iskulaite
FIU20060345U0 (fi) Pienoisgolf-rata